Work

Supplementary Table S1 from Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table S1 from Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response

DOI: 10.1158/1078-0432.22441779

Authors: Zhigang Kang, Jun-Jie Chen, Yunkai Yu, Bo Li, Shi-Yong Sun, Baolin Zhang, Liang Cao

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361971344

Cites:

Cited by:

Related to: 10